The case of an MSI cancer in the setting of MYH biallelic germline mutation reported in our study clearly does not support this hypothesis, and it is interesting that MLH1 was inactivated by biallelic promoter methylation, rather than through somatic mutations secondary to loss of MYH function. Here, MLH1 is linked to cancer.